Related Experiment Video
Updated: Sep 19, 2025
06:39
Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
5.7K
PLA2R1 Overexpression Causes Podocyte Injury by Inhibiting the Cell Cycle: A Clinical Cross-Sectional Investigation
Summary
Phospholipase A2 receptor 1 (PLA2R1) overexpression inhibits human podocyte proliferation, impacting primary membranous nephropathy (PMN) progression. This suggests PLA2R1-related PMN pathogenesis may involve additional immune responses.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Phospholipase A2 receptor 1 (PLA2R1) is a key diagnostic marker in primary membranous nephropathy (PMN).
- A subset of PMN patients exhibit PLA2R1 antigen positivity without detectable antibodies, suggesting distinct pathogenic mechanisms.
Purpose of the Study:
- To investigate the clinical features and cellular mechanisms in PMN patients positive for PLA2R1 antigen but negative for PLA2R1 antibodies.
- To elucidate the impact of PLA2R1 overexpression on human podocytes (HPCs).
Main Methods:
- Retrospective analysis of 26 PMN patients with PLA2R1 antigen positivity.
- In vitro studies involving PLA2R1 overexpression in human podocytes.
- RNA sequencing and Fluorescence-activated cell sorting (FACS) assays.
Main Results:
- A negative correlation was observed between blood albumin levels and PLA2R1 antigen intensity.
- PLA2R1 overexpression significantly inhibited HPC proliferation and viability.
- PLA2R1 overexpression led to cell cycle arrest in the S and G2/M phases of HPCs.
Conclusions:
- PLA2R1 overexpression disrupts the podocyte cell cycle, contributing to PMN progression.
- The findings suggest that PLA2R1-related PMN pathogenesis may involve additional immune mechanisms beyond antibody production.
- This research provides insights for developing novel therapeutic strategies for PMN.
